asparagine has been researched along with Bile Duct Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hafeji, YA; Lobl, MB; Mohr, AM; Mott, JL; Phillips, AJ; Safranek, HR | 1 |
| Noda, T; Ortiz, V; Shimoda, M; Sirica, AE; Wands, JR | 1 |
2 other study(ies) available for asparagine and Bile Duct Cancer
| Article | Year |
|---|---|
Glycosylation of FGFR4 in cholangiocarcinoma regulates receptor processing and cancer signaling.
Topics: Asparagine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fibroblast Growth Factors; Glycosylation; Humans; Mannose; Polysaccharides; Receptor, Fibroblast Growth Factor, Type 4 | 2022 |
Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.
Topics: Adoptive Transfer; Animals; Asparagine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Division; Cells, Cultured; Cholangiocarcinoma; Dendritic Cells; Disease Models, Animal; Humans; Immunization; Interleukin-12; Male; Rats; Rats, Inbred F344; Recombinant Proteins; Spleen | 2012 |